id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-343472-fd34ls35	Tersalvi, Gregorio	Emerging evidence of myocardial injury in COVID-19: A path through the smoke	2020-08-02		.txt	text/plain	966	55	42	In a situation such as the worldwide COVID-19 pandemic, where healthcare resources are placed under enormous stress, readily available tests such as this play an important role in helping clinicians identify patients at greater risk of developing severe forms of the disease, and should be included in the initial triage panel. Their value as prognostic markers in COVID-19 has been shown by several studies, since patients with higher troponin levels were more likely to be admitted to intensive care [8] and showed higher in-hospital mortality [2, 4, 6] . The Authors confirmed the known correlation between cardiac troponin and disease severity and showed a greater mortality in patients with elevated hs-cTnI levels. Given the accumulating evidence, a cardiac troponin assay should be included in the laboratory triage panel of patients with suspected of confirmed COVID-19, along with inflammatory and coagulation cascade activation markers (i.e. d-dimer), as it may help clinicians identify those who portend a higher risk of developing severe forms of the disease. COVID-19: Coronavirus disease 2019; hs-cTnI: high sensitivity cardiac troponin I.	./cache/cord-343472-fd34ls35.txt	./txt/cord-343472-fd34ls35.txt